Related Experiment Video
Updated: Jun 2, 2025

05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
11.2K
XGBoost-based nomogram for predicting lymph node metastasis in endometrial carcinoma
Xiaoting Lin1, Fumin Gao2, Haijiao Lin3
1Department of Reproductive Medicine, The First Affiliated Hospital, Jinan University Guangzhou 510000, Guangdong, China.
American Journal of Cancer Research
|January 13, 2025
Summary
Machine learning models accurately predict lymph node metastasis (LNM) risk in endometrial carcinoma (EC) patients. The XGBoost model offers valuable clinical support for surgical decisions and personalized treatment plans.
Area of Science:
- Oncology
- Medical Informatics
- Biostatistics
Background:
- Endometrial carcinoma (EC) poses a significant health challenge, with lymph node metastasis (LNM) being a critical prognostic factor.
- Accurate identification of EC patients at high risk for LNM is essential for effective clinical decision-making and treatment planning.
Purpose of the Study:
- To develop and optimize machine learning models for predicting LNM risk in EC patients.
- To enhance the accuracy of identifying high-risk LNM patients for improved clinical management.
- To provide data-driven support for surgical decisions and individualized treatment strategies in EC.
Main Methods:
- Retrospective analysis of 541 EC cases with diverse clinical and pathological variables.
- Utilized multivariate Logistic regression to identify independent risk factors for LNM.
- Applied machine learning algorithms including LASSO, XGBoost, RandomForest, and SVM for feature selection and model construction.
Main Results:
- The XGBoost model demonstrated superior performance, achieving AUCs of 0.876 (training) and 0.832 (validation).
- Calibration curve analysis confirmed the model's consistency and applicability across various risk levels.
- Decision curve analysis indicated significant clinical utility and net benefits for the XGBoost model.
Conclusions:
- Machine learning models, particularly XGBoost, effectively predict LNM risk in EC patients using clinical and pathological data.
- The developed model offers valuable insights for clinicians in surgical decision-making and personalized treatment planning.
- This approach has the potential to improve patient outcomes through more precise risk stratification and tailored interventions.

